139 related articles for article (PubMed ID: 29693778)
1. Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis.
Floresta G; Amata E; Dichiara M; Marrazzo A; Salerno L; Romeo G; Prezzavento O; Pittalà V; Rescifina A
ChemMedChem; 2018 Jul; 13(13):1336-1342. PubMed ID: 29693778
[TBL] [Abstract][Full Text] [Related]
2. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.
Floresta G; Rescifina A; Marrazzo A; Dichiara M; Pistarà V; Pittalà V; Prezzavento O; Amata E
Eur J Med Chem; 2017 Oct; 139():884-891. PubMed ID: 28866257
[TBL] [Abstract][Full Text] [Related]
3. Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors.
Amata E; Marrazzo A; Dichiara M; Modica MN; Salerno L; Prezzavento O; Nastasi G; Rescifina A; Romeo G; Pittalà V
ChemMedChem; 2017 Nov; 12(22):1873-1881. PubMed ID: 28708269
[TBL] [Abstract][Full Text] [Related]
4. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.
Floresta G; Apirakkan O; Rescifina A; Abbate V
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200181
[TBL] [Abstract][Full Text] [Related]
5. Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products.
Floresta G; Amata E; Gentile D; Romeo G; Marrazzo A; Pittalà V; Salerno L; Rescifina A
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30759842
[TBL] [Abstract][Full Text] [Related]
6. Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis.
Floresta G; Pittalà V; Sorrenti V; Romeo G; Salerno L; Rescifina A
Bioorg Chem; 2018 Dec; 81():334-339. PubMed ID: 30189413
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
Curr Med Chem; 2018; 25(42):5803-5821. PubMed ID: 30674243
[TBL] [Abstract][Full Text] [Related]
8. How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling.
Carletta A; Tilborg A; Moineaux L; de Ruyck J; Basile L; Salerno L; Romeo G; Wouters J; Guccione S
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Aug; 71(Pt 4):447-54. PubMed ID: 26208625
[TBL] [Abstract][Full Text] [Related]
9. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
J R Soc Interface; 2013 Jan; 10(78):20120697. PubMed ID: 23097500
[TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR assisted identification of selective CYP1B1 inhibitors: an effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis.
Raju B; Sapra B; Silakari O
Mol Divers; 2023 Dec; 27(6):2673-2693. PubMed ID: 36441444
[TBL] [Abstract][Full Text] [Related]
11. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
[TBL] [Abstract][Full Text] [Related]
14. A focus on heme oxygenase-1 (HO-1) inhibitors.
Pittalà V; Salerno L; Romeo G; Modica MN; Siracusa MA
Curr Med Chem; 2013; 20(30):3711-32. PubMed ID: 23746277
[TBL] [Abstract][Full Text] [Related]
15. Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
Salerno L; Floresta G; Ciaffaglione V; Gentile D; Margani F; Turnaturi R; Rescifina A; Pittalà V
Eur J Med Chem; 2019 Apr; 167():439-453. PubMed ID: 30784878
[TBL] [Abstract][Full Text] [Related]
16. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.
Floresta G; Fallica AN; Romeo G; Sorrenti V; Salerno L; Rescifina A; Pittalà V
Bioorg Chem; 2020 Nov; 104():104310. PubMed ID: 33010625
[TBL] [Abstract][Full Text] [Related]
17. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors.
Rahman MN; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
J Med Chem; 2008 Oct; 51(19):5943-52. PubMed ID: 18798608
[TBL] [Abstract][Full Text] [Related]
18. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
Chaudhari P; Bari S
Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors.
Amata E; Marrazzo A; Dichiara M; Modica MN; Salerno L; Prezzavento O; Nastasi G; Rescifina A; Romeo G; Pittalà V
Data Brief; 2017 Dec; 15():281-299. PubMed ID: 29034293
[TBL] [Abstract][Full Text] [Related]
20. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
